The same physiology that drives these benefits, particularly delayed gastric emptying, also explains many of the complications seen in the ED
[10] [11] Whilst these medications have proven benefits for glycaemic control and weight loss, their effects on gastrointestinal function mean they can influence digestive symptoms, which is particularly relevant for individuals with pre-existing bowel conditions such as IBS
Diet, protein intake, resistance training, and sleep all interact with GLP-1 therapy in real ways
Slowing down gastric emptying is one of the ways tirzepatide (and semaglutide, for that matter) helps people lose weightit keeps food in your stomach longer, which helps you feel full
As a result of this volatility, investors may not be able to sell their common stock at or above the initial public offering price
The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging